Tag Archives: BioMarin

BioMarin to Present at the Goldman Sachs Global Healthcare Conference – Marketwatch

Posted on May 30, 2012 by admin

for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse(TM) (amifampridine), which has been approved by the European Commission for the treatment of Lambert Eaton … Bing News – Full Story … Continue reading →

Share
Posted in Phenylketonuria | Tagged , , , , , , , | Leave a comment

BioMarin Announces First Quarter 2012 Financial Results – msnbc.com

Posted on May 3, 2012 by admin

3Q 2012: Results for Phase II trial for PEG-PAL for PKU 3Q 2012: Results for Phase I trial for BMN-111 for achondroplasia in healthy volunteers 2H 2012: Results for Phase I/II trial for BMN-673 for solid tumors 4Q 2012: Results … Continue reading →

Share
Posted in Dwarfism | Tagged , , , , , , , | Leave a comment

BioMarin Pharma Says IND For BMN-111 For Achondroplasia Is Active – RTT News

Posted on January 8, 2012 by admin

(RTTNews) – BioMarin Pharmaceutical Inc. (BMRN: News ) announced that the Investigational New Drug or IND application for BMN-111, an analog of C-type Natriuretic Peptide or CNP, for achondroplasia is active. The company expects to initiate the Phase 1 … … Continue reading →

Share
Posted in Dwarfism | Tagged , , , , , , | Leave a comment